.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Mallinckrodt
Baxter
Julphar
Healthtrust
Daiichi Sankyo
Farmers Insurance
Citi
Novartis
US Department of Justice

Generated: November 20, 2017

DrugPatentWatch Database Preview

Hospira Company Profile

« Back to Dashboard

What is the competitive landscape for HOSPIRA, and what generic alternatives to HOSPIRA drugs are available?

HOSPIRA has five hundred and nine approved drugs.

There are seven US patents protecting HOSPIRA drugs on HOSPIRA drugs in the past three years. There are nine tentative approvals on HOSPIRA drugs.

There are sixty-eight patent family members on HOSPIRA drugs in thirty-seven countries and one hundred and ninety-one supplementary protection certificates in twelve countries.

Summary for Hospira

International Patents:68
US Patents:7
Tradenames:328
Ingredients:201
NDAs:509
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
gentamicin sulfate
INJECTABLE;INJECTION062588-006Jan 6, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
VERAPAMIL HYDROCHLORIDE
verapamil hydrochloride
SOLUTION;INTRAVENOUS070737-002May 6, 1987APRXNoYes► Subscribe► Subscribe► Subscribe
Hospira
CARBOCAINE
mepivacaine hydrochloride
INJECTABLE;INJECTION012250-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Hospira Inc
MEPIVACAINE HYDROCHLORIDE
mepivacaine hydrochloride
INJECTABLE;INJECTION040806-001Apr 28, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira
AMIKACIN SULFATE
amikacin sulfate
INJECTABLE;INJECTION064099-001Jun 20, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER
lidocaine hydrochloride
INJECTABLE;INJECTION088368-001Jul 31, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
PACLITAXEL
paclitaxel
INJECTABLE;INJECTION076131-001May 8, 2002APRXNoYes► Subscribe► Subscribe► Subscribe
Hospira
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
fluconazole
INJECTABLE;INJECTION076303-002Jul 29, 2004APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
sodium chloride
INJECTABLE;INJECTION019465-002Jul 15, 1985APRXYesNo► Subscribe► Subscribe► Subscribe
Hospira
AQUASOL A
vitamin a palmitate
INJECTABLE;INJECTION006823-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Hospira

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hospira
TRACRIUM PRESERVATIVE FREE
atracurium besylate
INJECTABLE;INJECTION018831-001Nov 23, 1983► Subscribe► Subscribe
Hospira
PRECEDEX
dexmedetomidine hydrochloride
INJECTABLE;INJECTION021038-002Mar 13, 2013► Subscribe► Subscribe
Hospira Inc
NIPENT
pentostatin
INJECTABLE;INJECTION020122-001Oct 11, 1991► Subscribe► Subscribe
Hospira
PRECEDEX
dexmedetomidine hydrochloride
INJECTABLE;INJECTION021038-003Mar 13, 2013► Subscribe► Subscribe
Hospira
PRECEDEX
dexmedetomidine hydrochloride
INJECTABLE;INJECTION021038-001Dec 17, 1999► Subscribe► Subscribe
Hospira
BRETYLOL
bretylium tosylate
INJECTABLE;INJECTION017954-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Hospira
PRECEDEX
dexmedetomidine hydrochloride
INJECTABLE;INJECTION021038-001Dec 17, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for HOSPIRA drugs

Drugname Dosage Strength Tradename Submissiondate
dexmedetomidine
Injection 4 mcg/mL, 20 mL vials
PRECEDEX
9/30/2015
dexmedetomidine
Injection4 mcg/mL, 50 mL and 100 mL vials
PRECEDEX
12/26/2013
argatroban in sodium chloride
Injection1 mg/mL, 50 mL vials
ARGATROBAN
12/16/2011
dexmedetomidine
Injection100 mcg/mL
PRECEDEX
4/8/2009
argatroban
Injection100 mg/mL, 2.5 mL vials
ARGATROBAN
9/24/2007

Non-Orange Book Patents for Hospira

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,436,033Methods of treatment using a dexmedetomidine premix formulation► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Hospira Drugs

Country Document Number Estimated Expiration
Eurasian Patent Organization005524► Subscribe
Denmark1069893► Subscribe
Japan2014508746► Subscribe
Poland343553► Subscribe
South Korea101632103► Subscribe
Japan5990832► Subscribe
Hungary0101498► Subscribe
Portugal1069893► Subscribe
Brazil9909872► Subscribe
Australia3149499► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Hospira Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB96/051United Kingdom► SubscribePRODUCT NAME: (S)-(-)-1-PROPYL-2',6'-PIPECOLOXYLIDIDE HYDROCHLORIDE MONOHYDRATE (GENERIC NAME: ROPIVACAINE MONOHYDROCHLORIDE MONOHYDRATE); REGISTERED: SE 12319 19950915; SE 12322 19950915; SE 12323 19950915; UK 0017/0375 19960517; UK 0017/0376 19960517; UK 0017/0377 19960517; UK 0017/0378 19960517
C/GB12/058United Kingdom► SubscribePRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003
678Luxembourg► SubscribePRODUCT NAME: TOBRAMYCINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE QUI EN DERIVE. FIRST REGISTRATION: 20110725
C/GB97/005United Kingdom► SubscribePRODUCT NAME: DOLASETRON, OR A PHARMACEUTICALLY-ACCEPTABLE ACID ADDITION OR QUATERNARY AMMONIUM SALT THEREOF; REGISTERED: UK 04425/0150 19960926
C/GB98/025United Kingdom► SubscribePRODUCT NAME: MONTELUKAST, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREFERABLY MONTELUKAST SODIUM; REGISTERED: FI 12766 19970825; FI 12767 19970825; UK 00025/0357 19980115; UK 00025/0358 19980115
90026-1Sweden► SubscribePRODUCT NAME: 4-AMINOPYRIDIN ELLER ETT SALT ELLER SOLVAT DAERAV; REG. NO/DATE: EU/1/11/699/001 20110720
0722Netherlands► SubscribePRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720
C/GB08/018United Kingdom► SubscribePRODUCT NAME: FOSAMPRENAVIR CALCIUM: ((1S,2R)-3-(((4-AMINOPHENYL)SULFONYL)(2-METHYLPROPYL)AMINO)-1-(PHENYLMETHYL)-2(PHOSPHONOOXY)PROPYL)-CARBABAMIC ACID C-((3S)-TETRAHYDRO-3-FURANYL) ESTER CALCIUM SALT; REGISTERED: UK EU/1/04/282/001 20040712; UK EU/1/04/282/002 20040712
0483Netherlands► SubscribePRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMTRIHYDRAAT; NATIONAL REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: GB PL 17091/0263 - 0001 20101105
2014000024Germany► SubscribePRODUCT NAME: FENTANYL IN ALLEN DEM SCHUTZ DES GRUNDPATENTS UNTERLIEGENDEN FORMEN; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100831
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Cerilliant
Daiichi Sankyo
Citi
Deloitte
UBS
Colorcon
US Department of Justice
Chinese Patent Office
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot